Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study

被引：0

作者：

Suhler, Eric B. ^{[1
,2
]}

Jaffe, Glenn J. ^{[3
]}

Nguyen, Quan Dong ^{[4
]}

Brezin, Antoine P. ^{[5
]}

Zierhut, Manfred ^{[6
]}

Vitale, Albert ^{[7
]}

van Velthoven, Mirjam ^{[8
]}

Adan, Alfredo ^{[9
]}

Lim, Lyndell ^{[10
]}

Kramer, Michal ^{[11
]}

Schlaen, Ariel ^{[12
]}

Fortin, Eric ^{[13
]}

Muccioli, Cristina ^{[14
]}

Goto, Hiroshi ^{[15
]}

Kaburaki, Toshikatsu ^{[16
]}

Camez, Anne ^{[17
]}

Song, Alexandra P. ^{[18
]}

Kron, Martina ^{[17
]}

Tari, Samir ^{[18
]}

Dick, Andrew D. ^{[19
,20
,21
]}

机构：

[1] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA

[2] VA Portland Hlth Care Syst, Portland, OR USA

[3] Duke Univ, Durham, NC USA

[4] Univ Nebraska Med Ctr, Truhlsen Eye Inst, Omaha, NE USA

[5] Univ Paris 05, Hop Cochin, Paris, France

[6] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany

[7] Univ Utah, Salt Lake City, UT USA

[8] Rotterdam Eye Hosp, Rotterdam, Netherlands

[9] Hosp Clin Barcelona, Ophthalmol, Barcelona, Spain

[10] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Australia

[11] Tel Aviv Univ, Rabin Med Ctr, Tel Aviv, Israel

[12] Austral Univ, Buenos Aires, DF, Argentina

[13] Univ Montreal, Montreal, PQ, Canada

[14] Univ Fed Sao Paulo, Sao Paulo, Brazil

[15] Tokyo Med Univ, Tokyo, Japan

[16] Univ Tokyo, Sch Med, Ophthalmol, Bunkyo Ku, Tokyo, Japan

[17] Abbvie Deutschland GmbH & Co KG, Ludwigshafen, Germany

[18] AbbVie Inc, N Chicago, IL USA

[19] Univ Bristol, Bristol Eye Hosp, London, England

[20] Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England

[21] UCL, Inst Ophthalmol, London, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1335

引用

页数：2

共 50 条

[1] Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis
Claudia Fabiani
Antonio Vitale
Giacomo Emmi
Alice Bitossi
Giuseppe Lopalco
Jurgen Sota
Silvana Guerriero
Ida Orlando
Marco Capozzoli
Fiorella Fusco
Francesco Rana
Florenzo Iannone
Bruno Frediani
Mauro Galeazzi
Lorenzo Vannozzi
Gian Marco Tosi
Luca Cantarini
[J]. Clinical Rheumatology, 2019, 38 : 63 - 70
[2] Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis
Fabiani, Claudia
Vitale, Antonio
Emmi, Giacomo
Bitossi, Alice
Lopalco, Giuseppe
Sota, Jurgen
Guerriero, Silvana
Orlando, Ida
Capozzoli, Marco
Fusco, Fiorella
Rana, Francesco
Iannone, Florenzo
Frediani, Bruno
Galeazzi, Mauro
Vannozzi, Lorenzo
Tosi, Gian Marco
Cantarini, Luca
[J]. CLINICAL RHEUMATOLOGY, 2019, 38 (01) : 63 - 70
[3] Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis
Suhler, Eric B.
Jaffe, Glenn J.
Fortin, Eric
Lim, Lyndell L.
Merrill, Pauline T.
Dick, Andrew D.
Brezin, Antoine P.
Quan Dong Nguyen
Thorne, Jennifer E.
Van Calster, Joachim
Cimino, Luca
Adan, Alfredo
Goto, Hiroshi
Kaburaki, Toshikatsu
Kramer, Michal
Vitale, Albert T.
Kron, Martina
Song, Alexandra P.
Liu, Jianzhong
Pathai, Sophia
Douglas, Kevin M.
Schlaen, Ariel
Muccioli, Cristina
Van Velthoven, Mirjam E. J.
Zierhut, Manfred
Rosenbaum, James T.
[J]. OPHTHALMOLOGY, 2021, 128 (06) : 899 - 909
[4] Quiescence in Active and Inactive Non-Infectious, Intermediate, Posterior, or Panuveitis in Patients Treated with Adalimumab
Landewe, Robert
van der Horst-Bruinsma, Irene
Tari, Samir
Florentinus, Stefan
Song, Alexandra P.
Kron, Martina
Pathai, Sophia
Roseribaum, James T.
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
[5] Long-Term Efficacy and Safety of Adalimumab By Immunosuppressant Use in Patients with Non-Infectious Uveitis
Guex-Crosier, Yan
Foster, C. Stephen
Nakai, Kei
Goto, Hiroshi
Douglas, Kevin
Pathai, Sophia
Kron, Martina
Song, Alexandra P.
Van Calster, Joachim
Adan, Alfredo
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[6] The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study
Tao, Tianyu
Yang, Shizhao
He, Daquan
Peng, Xuening
Wang, Zhenyu
Jiang, Qi
Wang, Tianfu
Su, Wenru
[J]. OPHTHALMOLOGY AND THERAPY, 2024, 13 (05) : 1239 - 1253
[7] The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study
Tianyu Tao
Shizhao Yang
Daquan He
Xuening Peng
Zhenyu Wang
Qi Jiang
Tianfu Wang
Wenru Su
[J]. Ophthalmology and Therapy, 2024, 13 : 1239 - 1253
[8] LONG-TERM EFFICACY AND SAFETY OF ADALIMUMAB AS IMMUNOSUPPRESSANT IN PATIENTS WITH NON-INFECTIOUS UVEITIS IN THE VISUAL III TRIAL
Guex-Crosier, Yan
Foster, C.
Nakai, Kei
Goto, Hiroshi
Douglas, Kevin
Pathai, Sophia
Kron, Martina
Song, Alexandra
Van Calster, Joachim
Adan, Alfredo
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S87 - S88
[9] LONG-TERM EFFICACY AND SAFETY OF ADALIMUMAB BY AETIOLOGYIN PATIENTS WITH NON-INFECTIOUS UVEITIS IN THE VISUAL III TRIAL
Merrill, P. T.
Vitale, A.
Zierhut, M.
Fortin, E.
Goto, H.
Kron, M.
Song, A.
Douglas, K.
Pathai, S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1148 - 1148
[10] Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
Fabiani, Claudia
Vitale, Antonio
Rigante, Donato
Emmi, Giacomo
Bitossi, Alice
Lopalco, Giuseppe
Sota, Jurgen
Guerriero, Silvana
Orlando, Ida
Gentileschi, Stefano
Iannone, Florenzo
Frediani, Bruno
Galeazzi, Mauro
Vannozzi, Lorenzo
Tosi, Gian Marco
Cantarini, Luca
[J]. CLINICAL RHEUMATOLOGY, 2019, 38 (02) : 407 - 415

← 1 2 3 4 5 →